These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 23070966
21. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site. Finley JB, Atigadda VR, Duarte F, Zhao JJ, Brouillette WJ, Air GM, Luo M. J Mol Biol; 1999 Nov 12; 293(5):1107-19. PubMed ID: 10547289 [Abstract] [Full Text] [Related]
23. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Wang GT, Wang S, Gentles R, Sowin T, Maring CJ, Kempf DJ, Kati WM, Stoll V, Stewart KD, Laver G. Bioorg Med Chem Lett; 2005 Jan 03; 15(1):125-8. PubMed ID: 15582424 [Abstract] [Full Text] [Related]
24. Molecular insight into substrate recognition by human cytosolic sialidase NEU2. Mozzi A, Mazzacuva P, Zampella G, Forcella ME, Fusi PA, Monti E. Proteins; 2012 Apr 03; 80(4):1123-32. PubMed ID: 22228546 [Abstract] [Full Text] [Related]
25. Chemical synthesis of 4-trifluoromethylumbelliferyl-alpha-D-N-acetylneuraminic acid glycoside and its use for the fluorometric detection of poorly expressed natural and recombinant sialidases. Engstler M, Talhouk JW, Smith RE, Schauer R. Anal Biochem; 1997 Aug 01; 250(2):176-80. PubMed ID: 9245436 [Abstract] [Full Text] [Related]
33. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. Taylor NR, Cleasby A, Singh O, Skarzynski T, Wonacott AJ, Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell R, Colman P, Varghese J. J Med Chem; 1998 Mar 12; 41(6):798-807. PubMed ID: 9526556 [Abstract] [Full Text] [Related]
34. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q, Yang J, Liang K, Feng L, Li S, Wan J, Xu X, Yang G, Liu D, Yang S. J Chem Inf Model; 2008 Sep 12; 48(9):1802-12. PubMed ID: 18707092 [Abstract] [Full Text] [Related]
36. Building a successful structural motif into sialylmimetics-cyclohexenephosphonate monoesters as pseudo-sialosides with promising inhibitory properties. Streicher H, Busse H. Bioorg Med Chem; 2006 Feb 15; 14(4):1047-57. PubMed ID: 16230015 [Abstract] [Full Text] [Related]
37. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins. Hubschwerlen C, Angehrn P, Gubernator K, Page MG, Specklin JL. J Med Chem; 1998 Oct 08; 41(21):3972-5. PubMed ID: 9767634 [Abstract] [Full Text] [Related]